Table-II.
Comparison of visual outcome between the groups
| 6/6-6/18 | 6/24-6/36 | 6/60-3/60 | 2/60-HM | |
|---|---|---|---|---|
| Group A (Bevacizumab ) | 12 (30%) | 14 (35%) | 10 (25%) | 5 (12.5%) |
| Group B (Control) | 6 (14.6%) | 11 (26.8%) | 18 (43.9%) | 6 (14.6%) |
P=0.04
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.